SOPHARMA (SPH): Current report 95 buy back 27092012 - raport 95
UNI - EN REPORT No 95/2012
Podstawa prawna:
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
The Board of Directors of SOPHARMA AD (the "Company") hereby informs that from 20 September 2012 up to and including 26 September 2012 the Company bought 400 own shares representing 0.0003% of the share capital of the Company, to the total value of BGN 963.80 on the Bulgarian Stock Exchange. The average price per share was BGN 2.41.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.
The total number of own shares after these transactions is 3205655, representing 2.43% of the share capital of the Company.
Annexes:
File;
